|

Fluorine F 18 Flotufolastat Clinical Trials

1 actively recruiting trial across 1 location

Also known as: FLOTUFOLASTAT F-18, RHPSMA-7.3C

Pipeline

Phase 2: 1

Top Sponsors

  • Jonsson Comprehensive Cancer Center1

Indications

  • Prostate Carcinoma1
  • Cancer1

Los Angeles, California1 trial

An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.

UCLA / Jonsson Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.